Monocyte/macrophage mediates the impact of depression on Crohn's disease

Xin Zhang1, Pengbo Wang2, Yi Yang1

  • 1Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.

Insights

Depression negatively impacts Crohn's disease (CD) by altering monocytes/macrophages. These immune cells show reduced phagocytosis and increased inflammation, worsening CD prognosis.

Area of Science:

  • Immunology
  • Gastroenterology
  • Psychiatry

Background:

  • Depression is linked to increased Crohn's disease (CD) risk and poorer outcomes.
  • Monocytes and macrophages are key immune cells involved in both depression and CD pathogenesis.

Purpose of the Study:

  • To investigate if monocytes/macrophages mediate depression's effect on CD.
  • To examine alterations in monocyte/macrophage phagocytosis and cytokine production.
  • To assess the impact on CD4+ T lymphocyte differentiation and intestinal epithelial barrier function.

Main Methods:

  • Isolated monocytes/macrophages from CD patients (depressed vs. non-depressed).
  • Assessed phagocytosis, cytokine production (TNF-α, IL-6, IL-1β), and T cell subset differentiation (Th1, Th2, Th17, Treg).
  • Evaluated epithelial barrier integrity (Caco-2 cells) and tight junction protein expression.

Main Results:

  • Depressed CD patients showed decreased monocyte/macrophage phagocytosis and elevated pro-inflammatory cytokines (TNF-α, IL-6, IL-1β).
  • Monocytes from depressed patients promoted Th1/Th17 differentiation and suppressed Treg cells.
  • Macrophages from depressed patients impaired epithelial barrier function, reducing TEER and tight junction proteins.

Conclusions:

  • Monocyte/macrophage dysfunction contributes to depression's negative impact on CD.
  • Mechanisms include reduced phagocytosis, increased inflammation, skewed T cell differentiation, and compromised epithelial barrier integrity.
Abstract

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
195
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
173
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
149
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
285
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
354
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
274